Christopher E. Duymich

536 total citations
8 papers, 355 citations indexed

About

Christopher E. Duymich is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Christopher E. Duymich has authored 8 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Christopher E. Duymich's work include Epigenetics and DNA Methylation (7 papers), Renal cell carcinoma treatment (2 papers) and Cancer-related gene regulation (2 papers). Christopher E. Duymich is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Renal cell carcinoma treatment (2 papers) and Cancer-related gene regulation (2 papers). Christopher E. Duymich collaborates with scholars based in United States, Denmark and South Korea. Christopher E. Duymich's co-authors include Gangning Liang, Peter A. Jones, Jessica Charlet, Xiaojing Yang, Daniel J. Weisenberger, Karina D. Sørensen, Kamilla Mundbjerg, Hongtao Li, Fides D. Lay and Ranjani Lakshminarasimhan and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Research.

In The Last Decade

Christopher E. Duymich

8 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Duymich United States 6 299 67 58 45 38 8 355
Elo Madissoon Finland 7 234 0.8× 38 0.6× 44 0.8× 66 1.5× 49 1.3× 10 318
Marta Ferreira Portugal 6 87 0.3× 47 0.7× 46 0.8× 34 0.8× 17 0.4× 16 177
Alka Singh India 9 138 0.5× 119 1.8× 33 0.6× 31 0.7× 16 0.4× 24 255
Yuqian Zhou China 8 118 0.4× 76 1.1× 74 1.3× 79 1.8× 24 0.6× 37 271
Anqi Cheng China 11 249 0.8× 187 2.8× 60 1.0× 26 0.6× 22 0.6× 24 360
Kurinji Pandiyan United States 6 235 0.8× 21 0.3× 15 0.3× 20 0.4× 36 0.9× 7 262
Christin Lund‐Andersen Norway 7 109 0.4× 37 0.6× 29 0.5× 38 0.8× 29 0.8× 16 188
Sue Naim United States 5 233 0.8× 37 0.6× 17 0.3× 18 0.4× 15 0.4× 8 299
Mayuko Inuzuka Japan 6 78 0.3× 58 0.9× 73 1.3× 37 0.8× 87 2.3× 11 249
Vera Riehmer Germany 7 142 0.5× 46 0.7× 31 0.5× 14 0.3× 54 1.4× 11 229

Countries citing papers authored by Christopher E. Duymich

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Duymich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Duymich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Duymich more than expected).

Fields of papers citing papers by Christopher E. Duymich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Duymich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Duymich. The network helps show where Christopher E. Duymich may publish in the future.

Co-authorship network of co-authors of Christopher E. Duymich

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Duymich. A scholar is included among the top collaborators of Christopher E. Duymich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Duymich. Christopher E. Duymich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mundbjerg, Kamilla, Sameer Chopra, Mehrdad Alemozaffar, et al.. (2017). Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome biology. 18(1). 3–3. 43 indexed citations
2.
Lakshminarasimhan, Ranjani, Claudia Andreu‐Vieyra, Kate Lawrenson, et al.. (2017). Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells. Cancer Letters. 401. 11–19. 39 indexed citations
3.
Nishiyama, Naotaka, Stephanie G. Yi, Christopher E. Duymich, et al.. (2017). MP98-02 A POTENTIAL ROLE OF ABERRANT DNA METHYLATION IN THE CHEMORESISTANCE IN BLADDER CANCER CELLS. DNA METHYLATION INHIBITORS COULD RE-SENSITIZE DRUG-RESISTANCE BLADDER CANCER CELLS.. The Journal of Urology. 197(4S). 2 indexed citations
4.
Becket, Elinne, Sameer Chopra, Christopher E. Duymich, et al.. (2016). Identification of DNA Methylation–Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma. Cancer Research. 76(7). 1954–1964. 29 indexed citations
5.
Li, Hongtao, Christopher E. Duymich, Daniel J. Weisenberger, & Gangning Liang. (2016). Genetic and Epigenetic Alterations in Bladder Cancer. International Neurourology Journal. 20(Suppl 2). S84–94. 52 indexed citations
6.
Duymich, Christopher E., Jessica Charlet, Xiaojing Yang, Peter A. Jones, & Gangning Liang. (2016). DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nature Communications. 7(1). 11453–11453. 100 indexed citations
7.
Charlet, Jessica, Christopher E. Duymich, Fides D. Lay, et al.. (2016). Bivalent Regions of Cytosine Methylation and H3K27 Acetylation Suggest an Active Role for DNA Methylation at Enhancers. Molecular Cell. 62(3). 422–431. 89 indexed citations
8.
Becket, Elinne, Sameer Chopra, Christopher E. Duymich, et al.. (2016). Abstract B03: Identification of epigenetic regulated genes through simultaneous analysis of DNA methylation and chromatin structure in uncultured tumors. Cancer Research. 76(2_Supplement). B03–B03. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026